D-1550-2016 Class III Terminated
FDA drug recall D-1550-2016 was initiated by Mckesson Packaging Services on Sep 8, 2016 and is designated Class III. Reason for recall: Labeling: Label mix-up. The inner packaging was properly labeled Omeprazole DR 40mg Capsules, but the outer secondary packaging was mislabeled Lansoprazole Delayed-Release 30mg Capsules. The recall status is terminated (terminated May 3, 2017). Affected quantity: 181 unit cartons of 10 x 10 blister cards.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 5, 2016
- Initiation Date
- Sep 8, 2016
- Termination Date
- May 3, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 181 unit cartons of 10 x 10 blister cards
Product description
Lansoprazole Delayed-Release Capsules, USP, 30 mg, packaged in 100-count cartons of 10 x 10 unit dose blister cards, Rx only, Manufactured by: Dr. Reddy's Laboratories, Inc., 200 Somerset Corporate Blvd Floor 7, Bridgewater, NJ 08807, NDC 63739-0555-10
Reason for recall
Labeling: Label mix-up. The inner packaging was properly labeled Omeprazole DR 40mg Capsules, but the outer secondary packaging was mislabeled Lansoprazole Delayed-Release 30mg Capsules.
Distribution pattern
Nationwide
Code information
Lot # 0111295, Exp 9/17
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1550-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026